---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-031372"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-21T23:12:13.915583+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# AgeX Therapeutics Q3 2022: Revenue $9K, cash $0.5M, substantial going concern doubt

## Summary
- Cash and equivalents $0.5M; company says cash insufficient for next 12 months, raising substantial going concern doubt.
- Total revenues $9,000 vs $24,000 prior-year quarter; R&D $0.2M, G&A $1.4M flat.
- Borrowed additional $1.0M under $13.16M Secured Note from Juvenescence; $1.5M remaining, draws at Juvenescence's discretion.
- $8M principal under earlier 2020 Loan Agreement due March 2023; Secured Note matures Feb 2024.

## SEC filing metadata
- accession: 0001493152-22-031372
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315222031372/0001493152-22-031372-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315222031372/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-031372
- JSON: https://secwatch.observer/filing/0001493152-22-031372.json
- Plain text: https://secwatch.observer/filing/0001493152-22-031372.txt

## Key facts
- Earnings Releases
  Serina Therapeutics, Inc. reported financial results for the three months ended September 30, 2022.
  - Period: the three months ended September 30, 2022
  - Result: reported results
  source text: On November 10, 2022, AgeX issued a press release announcing its financial results for the three months ended September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315222031372/0001493152-22-031372-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.